Central retinal artery occlusion due to giant cell arteritis: A case report
Keywords:
Central retinal artery occlusion, giant cell arteritisAbstract
Introduction: Reports of giant cell arteritis cases in Thailand remain limited, despite its clinical significance.
Objective: To describe the symptoms, clinical manifestations, ophthalmologic assessments, laboratory investigations, and histopathological characteristics of patient with Central retinal artery occlusion due to giant cell arteritis
Case presentation: This case report presents an elderly Thai male patient who experienced a sudden onset of bilateral vision loss accompanied by a persistent headache. Three weeks later, the patient developed progressively worsening headache, generalized fatigue, and jaw claudication for three days before seeking medical attention. A comprehensive clinical evaluation was performed, including visual acuity assessment and detailed fundoscopic examination. Laboratory investigations revealed significantly elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels. A temporal artery biopsy was subsequently conducted to confirm the diagnosis of giant cell arteritis (GCA). GCA is a systemic inflammatory disease affecting medium- to large-sized arteries, which can result in severe and irreversible vision loss. It is considered an ophthalmologic emergency that requires prompt recognition and urgent management. Early diagnosis and immediate initiation of corticosteroid therapy are critical in preventing permanent visual impairment and other complications.
Conclusion: The effective management of GCA necessitates a multidisciplinary approach, particularly involving collaboration between ophthalmologists and other medical specialists.
References
Attaseth T, Vanikieti K, Poonyathalang A, Preechawat P, Jindahra P, Wattanatranon D. Anterior ischemic optic neuropathy due to biopsy-proven giant cell arteritis in Thai patients. Clin Ophthalmol. 2015; 9: 1071-5.
Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Ophthalmology. 1994; 101: 1779-85.
Aui-Aree N, Tungsinmunkong K, Hirunpat S, Ratanasukon M, Wangsupadilok B. A variety of atypical manifestations in giant cell arteritis. J Med Assoc Thai. 2010; 93: 629-32.
Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: The first government supported nationwide survey. Arthritis Care Res. 2003; 49: 594-8.
Hayreh S. Central retinal artery occlusion. Indian J Ophthalmol. 2018; 66: 1684-94.
Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005; 140: 376-91.
Hayreh SS. Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol. 1974; 58: 964-80.
Ciofalo A, Gulotta G, Iannella G, Pasquariello B, Manno A, Angeletti D, et al. Giant cell arteritis (gca): pathogenesis, clinical aspects and treatment approaches. Curr Rheumatol Rev. 2019; 15: 259-68.
Hayreh SS. Giant cell arteritis: Its ophthalmic manifestations. Indian J Ophthalmol. 2021; 69: 227-35.
Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A. Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology. 2020; 59: 1011-20.
Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American college of rheumatology/vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis Rheumatol. 2021; 73: 1349-65.
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990; 33: 1122-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Burapha University

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.